Cart
sales@molnova.com
Buparvaquone
CAS No. 88426-33-9
Buparvaquone ( —— )
Catalog No. M19227 CAS No. 88426-33-9
Buparvaquone is a hydroxynaphthoquinone antiprotozoal drug related to parvaquone and atovaquone.
Purity : 98%
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 10MG | 38 | In Stock |
|
| 50MG | 52 | In Stock |
|
| 100MG | 67 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBuparvaquone
-
NoteResearch use only, not for human use.
-
Brief DescriptionBuparvaquone is a hydroxynaphthoquinone antiprotozoal drug related to parvaquone and atovaquone.
-
DescriptionBuparvaquone is a hydroxynaphthoquinone antiprotozoal drug related to parvaquone and atovaquone.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptorothers
-
Research AreaInfection
-
Indication——
Chemical Information
-
CAS Number88426-33-9
-
Formula Weight326.44
-
Molecular FormulaC21H26O3
-
Purity98%
-
SolubilityDMSO : 33.33 mg/mL 102.10 mM;
-
SMILESCC(C)(C)C1CCC(CC2=C(O)C(=O)c3ccccc3C2=O)CC1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Müller J, et al. Buparvaquone is active against Neospora caninum in vitro and in experimentally infected mice. Int J Parasitol Drugs Drug Resist. 2015 Feb 13;5(1):16-25.
molnova catalog
related products
-
Octahydroaminoacridi...
Octahydroaminoacridine succinate, an acetylcholinesterase inhibitor, is used potentially for the treatment of Alzheimer's disease.
-
AG1024
AG-1024 (Tyrphostin) suppresses IGF-1R autophosphorylation(IC50=7 μM), and is less potent for IR(IC50=57 μM).
-
Monnieriside G
Monnieriside G is a natural product from Cnidium monnieri.
